270 related articles for article (PubMed ID: 17445439)
1. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
2. Renal biopsy in lupus patients with low levels of proteinuria.
Christopher-Stine L; Siedner M; Lin J; Haas M; Parekh H; Petri M; Fine DM
J Rheumatol; 2007 Feb; 34(2):332-5. PubMed ID: 17183619
[TBL] [Abstract][Full Text] [Related]
3. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
Hsieh YP; Wen YK; Chen ML
Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
[TBL] [Abstract][Full Text] [Related]
5. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
6. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.
Ikuma D; Hiromura K; Kajiyama H; Suwa J; Ikeuchi H; Sakairi T; Kaneko Y; Maeshima A; Kurosawa H; Hirayama Y; Yokota K; Araki Y; Sato K; Asanuma YF; Akiyama Y; Hara M; Nojima Y; Mimura T
Lupus; 2018 Mar; 27(3):484-493. PubMed ID: 29050536
[TBL] [Abstract][Full Text] [Related]
7. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
[TBL] [Abstract][Full Text] [Related]
8. Urinary podocytes for the assessment of disease activity in lupus nephritis.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
Am J Med Sci; 2000 Aug; 320(2):112-6. PubMed ID: 10981486
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin expression in renal tissues and correlation with the number of urinary podocytes in children with Henoch-Schonlein purpura nephritis.
Huang D; Wu X; Zheng W; Peng X; He X; Mo S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):161-7. PubMed ID: 22561433
[TBL] [Abstract][Full Text] [Related]
10. Value of immunohistochemical expression of podocalyxin in active lupus nephritis.
Behairy MA; Shakweer MM; El Said TW; ElGharbawy NH
Nefrologia (Engl Ed); 2018; 38(1):64-72. PubMed ID: 28757276
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for urinary podocyte excretion assessment in lupus nephritis?
Mansur JB; Sabino AR; Nishida SK; Kirsztajn GM
Ren Fail; 2016; 38(4):643-7. PubMed ID: 26906105
[TBL] [Abstract][Full Text] [Related]
12. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
Lu F; Shen W; Zhang X; Guo M; Lin S
Chin Med J (Engl); 2000 Dec; 113(12):1082-6. PubMed ID: 11776141
[TBL] [Abstract][Full Text] [Related]
15. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
[TBL] [Abstract][Full Text] [Related]
16. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic correlations in lupus nephritis in Lima, Peru.
Hurtado A; Asato C; Escudero E; Stromquist CS; Urcia J; Hurtado ME; de La Cruz S; Wener MH; Zavala R; Johnson RJ
Nephron; 1999; 83(4):323-30. PubMed ID: 10575294
[TBL] [Abstract][Full Text] [Related]
18. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
19. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
